Fundraising FoxHealthCap — 2012 Investments
1 investments dated 2012 · listed companies and verified rows first · show all
FerroKin BiosciencesinSeries B · Feb 2012 · $12Macquired by Shire
Developed a next-generation iron chelator for iron overload in transfusion-dependent anemia; acquired by Shire in 2012.
BiotechSan Carlos, US
Hugh Y. Rienhoff, Jr., M.D.(Executive Officer, Director)in
BoardMarten Steen(Director)inDennis Henner, Ph.D.(Director)Bryant E. Fong(Director)
Co-investorsMC Healthcare VenturesClarus Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.